Northern Trust’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-2,468,275
| Closed | -$281K | – | 4287 |
|
|
2018
Q4 | $281K | Sell |
2,468,275
-602,674
| -20% | -$395K | ﹤0.01% | 3698 |
|
|
2018
Q3 | $5.22M | Buy |
3,070,949
+129,219
| +4% | +$231K | ﹤0.01% | 2660 |
|
|
2018
Q2 | $5.12M | Buy |
2,941,730
+8,711
| +0.3% | +$15.1K | ﹤0.01% | 2672 |
|
|
2018
Q1 | $5.37M | Buy |
2,933,019
+18,935
| +0.6% | +$40K | ﹤0.01% | 2536 |
|
|
2017
Q4 | $6.5M | Buy |
2,914,084
+157,639
| +6% | +$392K | ﹤0.01% | 2448 |
|
|
2017
Q3 | $7.99M | Sell |
2,756,445
-48,323
| -2% | -$165K | ﹤0.01% | 2336 |
|
|
2017
Q2 | $12.5M | Buy |
2,804,768
+372,683
| +15% | +$1.54M | ﹤0.01% | 2024 |
|
|
2017
Q1 | $11.3M | Buy |
2,432,085
+341,312
| +16% | +$1.98M | ﹤0.01% | 2034 |
|
|
2016
Q4 | $12.7M | Buy |
2,090,773
+86,477
| +4% | +$452K | ﹤0.01% | 1935 |
|
|
2016
Q3 | $11M | Sell |
2,004,296
-7,460
| -0.4% | -$34.9K | ﹤0.01% | 2006 |
|
|
2016
Q2 | $7.64M | Buy |
2,011,756
+900,432
| +81% | +$3.05M | ﹤0.01% | 2196 |
|
|
2016
Q1 | $3.07M | Sell |
1,111,324
-7,664
| -0.7% | -$27.8K | ﹤0.01% | 2734 |
|
|
2015
Q4 | $6.34M | Buy |
1,118,988
+51,454
| +5% | +$314K | ﹤0.01% | 2318 |
|
|
2015
Q3 | $5.66M | Buy |
1,067,534
+30,044
| +3% | +$233K | ﹤0.01% | 2364 |
|
|
2015
Q2 | $8.61M | Buy |
1,037,490
+38,434
| +4% | +$186K | ﹤0.01% | 2158 |
|
|
2015
Q1 | $4.62M | Sell |
999,056
-1,101
| -0.1% | -$3.58K | ﹤0.01% | 2554 |
|
|
2014
Q4 | $3.05M | Sell |
1,000,157
-42,250
| -4% | -$125K | ﹤0.01% | 2821 |
|
|
2014
Q3 | $2.9M | Buy |
1,042,407
+110,897
| +12% | +$402K | ﹤0.01% | 2854 |
|
|
2014
Q2 | $3.79M | Sell |
931,510
-92,412
| -9% | -$393K | ﹤0.01% | 2713 |
|
|
2014
Q1 | $5.44M | Sell |
1,023,922
-113,139
| -10% | -$634K | ﹤0.01% | 2501 |
|
|
2013
Q4 | $6.31M | Buy |
1,137,061
+26,566
| +2% | +$115K | ﹤0.01% | 2397 |
|
|
2013
Q3 | $5M | Buy |
1,110,495
+273,298
| +33% | +$1.23M | ﹤0.01% | 2505 |
|
|
2013
Q2 | $3.57M | Buy |
+837,197
| New | +$4.21M | ﹤0.01% | 2631 |
|
Other funds holding SGYP
Northern Trust's SGYP Position: Q1 2019 in Review
Northern Trust sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 2,468,275 shares — an estimated $281K sold.
Northern Trust first reported a position in SGYP in Q2 2013 and held it in 23 quarters. The position peaked at $12.7M in Q4 2016. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.
- Northern Trust reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
- Northern Trust sold 2,468,275 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $281K.
- Northern Trust first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 23 quarters.
- Northern Trust's Synergy Pharmaceuticals, Inc Common Stock position peaked at $12.7M in Q4 2016.
- 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.
Based on Northern Trust's 13F filing for Q1 2019, filed 13 May 2019.